— The company has launched an internal probe into transactions undertaken for the purpose of generating foreign exchange gains or losses. The transactions used a convention that was not in accordance with GAAP, leading to some misstatements in the previously reported operating income. Baxter did not give an end date for the probe.
— For 4Q19, Baxter sees sales growth of 3-4% on a reported basis and approximately 5% on a constant currency basis. Operating margin is expected between 15.2% and 15.9% on a reported basis and between 18.5% and 19% on an adjusted basis.
— BAX shares fell 6.5 immediately following the earnings announcement.
ADVERTISEMENT